CureVac NV (NASDAQ:CVAC)
| 84.89 Delayed Data As of 5:24pm ET |  +5.20 / +6.53%Today’s Change | 36.15 Today|||52-Week Range 85.68 | -- Year-to-Date |
Latest CVAC News | Press Releases
| Is There Room for Latecomers to the COVID-19 Party? Nov 21 / MotleyFool.com - Paid Partner Content | 3 Best Biotech Stocks to Buy Right Now Nov 14 / MotleyFool.com - Paid Partner Content |
| 3 mRNA Coronavirus Vaccine Stocks to Check Out That Aren't Pfizer, BioNTech, or Moderna Nov 17 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 79.69 |
| Today’s open | 82.21 |
| Day’s range | 81.70 - 85.00 |
| Volume | 33,433 |
| Average volume (3 months) | 25,444 |
| Market cap | -- |
Data as of 5:24pm ET, 11/23/2020
Growth & Valuation
| Earnings growth (last year) | -33.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +28.37% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $19.5M |
| Annual profit (last year) | -$111.8M |
| Net profit margin | -573.46% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
